Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combining Electroacupuncture With Antiemetic Therapy for Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer: A Clinical Study

NCT06314906 is registered in ClinicalTrials.gov with Feixue Song as lead sponsor.

NCT NCT06314906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06314906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combining Electroacupuncture With Antiemetic Therapy for Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer: A Clinical Study
Lead sponsor
Feixue Song
Phase
Phase 3
Overall status
Recruiting
Start date
March 7, 2024
Completion date
March 31, 2027
Enrollment
370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electroacupuncture, nausea and vomiting, olanzapine-contained four-drug antiemetic